Literature DB >> 20007681

Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.

Wanwarat Ananthapanyasut1, Sirikarn Napan, Earl H Rudolph, Tasma Harindhanavudhi, Husam Ayash, Kelly E Guglielmi, Edgar V Lerma.   

Abstract

BACKGROUND AND OBJECTIVES: Chronic kidney disease (CKD) increases systemic inflammation, which is implicated in development and maintenance of atrial fibrillation (AF); therefore, we hypothesized that the prevalence of AF would be increased among nondialysis patients with CKD. This study also reports independent predictors of the presence of AF in this population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective, cross-sectional analysis of 1010 consecutive nondialysis patients with CKD from two community-based hospitals was conducted. Estimated GFRs (eGFRs) were calculated using the Modification of Diet in Renal Disease (MDRD) equation. Multivariate logistic regression was used to determine independent predictors.
RESULTS: Of 1010 nondialysis patients with CKD, 214 (21.2%) had AF. Patients with AF were older than patients without AF (76 +/- 11 versus 63 +/- 15 yr). The prevalence of AF among white patients (42.7%) was higher than among black patients (12.7%) or other races (5.7%). In multivariate analyses, age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure were identified as independent predictors of the presence of AF. Although serum high-sensitivity C-reactive protein levels were elevated in our population (5.2 +/- 7.4 mg/L), levels did not correlate with the presence of AF or with eGFR. Finally, eGFR did not correlate with the presence of AF in our population.
CONCLUSIONS: The prevalence of AF was increased in our population, and independent predictors were age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure.

Entities:  

Mesh:

Year:  2009        PMID: 20007681      PMCID: PMC2827597          DOI: 10.2215/CJN.03170509

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  48 in total

1.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)

Authors:  S Z Goldhaber; L Visani; M De Rosa
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  Frequency of atrial fibrillation and factors related to its development in dialysis patients.

Authors:  Ilyas Atar; Didem Konaş; Sadik Açikel; Eyüp Külah; Asli Atar; Hüseyin Bozbaş; Oykü Gülmez; Siren Sezer; Aylin Yildirir; Nurhan Ozdemir; Haldun Müderrisoğlu; Bülent Ozin
Journal:  Int J Cardiol       Date:  2006-01-04       Impact factor: 4.164

3.  Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients.

Authors:  Simonetta Genovesi; Daniela Pogliani; Andrea Faini; Maria G Valsecchi; Alessandra Riva; Francesca Stefani; Irene Acquistapace; Andrea Stella; Giuseppe Bonforte; Amedeo DeVecchi; Vincenzo DeCristofaro; Gherardo Buccianti; Antonio Vincenti
Journal:  Am J Kidney Dis       Date:  2005-11       Impact factor: 8.860

4.  Inflammatory markers according to types of atrial fibrillation.

Authors:  Omer Gedikli; Abdullah Dogan; Irfan Altuntas; Ahmet Altinbas; Mehmet Ozaydin; Onur Akturk; Gurkan Acar
Journal:  Int J Cardiol       Date:  2007-01-19       Impact factor: 4.164

5.  Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Authors:  Jeff S Healey; Adrian Baranchuk; Eugene Crystal; Carlos A Morillo; Michael Garfinkle; Salim Yusuf; Stuart J Connolly
Journal:  J Am Coll Cardiol       Date:  2005-06-07       Impact factor: 24.094

6.  Obesity and the risk of new-onset atrial fibrillation.

Authors:  Thomas J Wang; Helen Parise; Daniel Levy; Ralph B D'Agostino; Philip A Wolf; Ramachandran S Vasan; Emelia J Benjamin
Journal:  JAMA       Date:  2004-11-24       Impact factor: 56.272

7.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

8.  Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.

Authors:  Simonetta Genovesi; Antonio Vincenti; Emanuela Rossi; Daniela Pogliani; Irene Acquistapace; Andrea Stella; Maria Grazia Valsecchi
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

9.  C-reactive protein as an outcome predictor for maintenance hemodialysis patients.

Authors:  W F Owen; E G Lowrie
Journal:  Kidney Int       Date:  1998-08       Impact factor: 10.612

10.  Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

Authors:  R M Bologa; D M Levine; T S Parker; J S Cheigh; D Serur; K H Stenzel; A L Rubin
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

View more
  52 in total

1.  Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Xuan Cai; Jungwha Lee; Julia J Scialla; Nisha Bansal; James H Sondheimer; Jing Chen; L Lee Hamm; Ana C Ricardo; Sankar D Navaneethan; Rajat Deo; Mahboob Rahman; Harold I Feldman; Alan S Go; Tamara Isakova; Myles Wolf
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

2.  The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction.

Authors:  Hideki Koike; Toshisuke Morita; Junko Tatebe; Ippei Watanabe; Makiko Koike; Shintaro Yao; Masaya Shinohara; Hitomi Yuzawa; Takeya Suzuki; Tadashi Fujino; Takanori Ikeda
Journal:  Heart Vessels       Date:  2018-11-08       Impact factor: 2.037

3.  Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline.

Authors:  Catharina Jm Klijn; Maurizio Paciaroni; Eivind Berge; Eleni Korompoki; Janika Kõrv; Avtar Lal; Jukka Putaala; David J Werring
Journal:  Eur Stroke J       Date:  2019-04-09

4.  Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis.

Authors:  Tara I-Hsin Chang; Sai Liu; Medha Airy; Jingbo Niu; Mintu P Turakhia; Jennifer E Flythe; Maria E Montez-Rath; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-07       Impact factor: 8.237

5.  Cardiovascular disease: Coronary artery calcification predicts risk of CVD in patients with CKD.

Authors:  Paolo Raggi
Journal:  Nat Rev Nephrol       Date:  2017-05-08       Impact factor: 28.314

6.  Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.

Authors:  Hsin-Yu Chen; Shih-Hsiang Ou; Chien-Wei Huang; Po-Tsang Lee; Kang-Ju Chou; Pei-Chin Lin; Yi-Chia Su
Journal:  Clin Drug Investig       Date:  2021-03-11       Impact factor: 2.859

Review 7.  Role of direct oral anticoagulants in patients with kidney disease.

Authors:  Vimal K Derebail; Michelle N Rheault; Bryce A Kerlin
Journal:  Kidney Int       Date:  2019-12-24       Impact factor: 10.612

8.  Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.

Authors:  Peter A McCullough; Timothy Ball; Katy Mathews Cox; Manish D Assar
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

Review 9.  Differential impact of race and risk factors on incidence of atrial fibrillation.

Authors:  T David Gbadebo; Henry Okafor; Dawood Darbar
Journal:  Am Heart J       Date:  2011-07       Impact factor: 4.749

10.  Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project.

Authors:  Juan Jesus Carrero; Marco Trevisan; Manish M Sood; Peter Bárány; Hong Xu; Marie Evans; Leif Friberg; Karolina Szummer
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-20       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.